FORT WORTH, Texas–(BUSINESS WIRE)–Alcon, the global leader in eye care, today announced the debut of DAILIES® COLORS contact lenses that combine the beauty of eye color enhancement with the convenience of a daily disposable contact lens. The new line…
Category: Business
Avellino Labs Founder Gene Lee Receives 2019 Ellis Island Medal of Honor, Named to World Economic Forum’s Precision Medicine Council
MENLO PARK, Calif.–(BUSINESS WIRE)–Gene Lee, founder of genetic services provider, Avellino Labs, recognized by World Economic Forum and Ellis Island Honors Society.
Global Surgical Eye Care Market Size, Trends, and Forecasts (2019-2023): Dominated by Novartis, Carl Zeiss Stiftung, Johnson & Johnson, and Bausch Health Companies – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Surgical Eye Care Market: Size, Trends, Forecasts (2019-2023)” report has been added to ResearchAndMarkets.com’s offering. The global surgical eye care market has observed constant growth in the past few years and projections are made that in the forecasted period (2019-2023) the market would propel with a steady growth rate. The global surgical eye care market would be supported by the growth drivers such as rising incidences of vision impairment disorders,
Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
WATERTOWN, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2017 Equity Incentive Plan in accordance with …
EnChroma Expands Leadership Team With Key Hires, Adds Over 100 New Retail Partners in the US, Europe and Canada
BERKELEY, Calif. & ST. LOUIS–(BUSINESS WIRE)–<a href="https://twitter.com/hashtag/colorishere?src=hash" target="_blank">#colorishere</a>–EnChroma Expands Leadership Team with Key Hires, Adds Over 100 New Retail Pa…
RIBOMIC annonce les premiers résultats positifs de l'essai clinique de phase 1/2a du RBM-007 (étude SUSHI) chez des patients atteints de dégénérescence maculaire liée à l'âge humide
TOKYO–(BUSINESS WIRE)–RIBOMIC, Inc., société pharmaceutique de stade clinique spécialisée dans les produits thérapeutiques à aptamères et cotée sur le Mothers Market de la Bourse de Tokyo (numéro de code : 4591), a annoncé aujourd’hui les premiers résultats positifs issus de l’étude SUSHI, étude clinique à dose ascendante unique de Phase 1/2a du RBM-007, aptamère anti-FGF2, chez neuf patients atteints de dégénérescence maculaire liée à l’âge humide (DMLA humide). L’étude SUSHI a atteint le cr
RIBOMIC gibt positive Topline-Ergebnisse der klinischen Phase-1/2a-Studie an RBM-007 (SUSHI-Studie) bei Patienten mit feuchter altersbedingter Makuladegeneration bekannt
TOKIO–(BUSINESS WIRE)–RIBOMIC, Inc., ein auf Aptamer-Therapeutika im klinischen Stadium spezialisiertes Pharmaunternehmen, das am Mothers-Markt der Tokioter Börse gehandelt wird (Börsenkürzel: 4591), gab heute positive Topline-Ergebnisse seiner SUSHI…
Global Sunglasses Market Projected to Reach $38.84 Billion by 2024 – Key Players Focus to Leverage Opportunities Posed by Emerging Markets to Expand Their Product Portfolio – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Sunglasses Market – Growth, Trends and Forecasts (2019 – 2024)” report has been added to ResearchAndMarkets.com’s offering. Global sunglasses market is forecasted to reach USD 38.84 billion by 2024 growing at a CAGR of 5.5% during the forecast period (2019-2024). Key Highlights The growth rate of sunglasses is driven by the increased consumer awareness and demand for protection against ultraviolet radiation and glare, as well as the growing popularity of sunglasses
RIBOMIC Announces Positive Top-Line Results from the Phase 1/2a Clinical Trial of RBM-007 (SUSHI Study) in Subjects with Wet Age-Related Macular Degeneration
TOKYO–(BUSINESS WIRE)–RIBOMIC, Inc., a clinical stage pharmaceutical company specializing in aptamer therapeutics and traded on the Mothers Market of the Tokyo Stock Exchange (Code Number: 4591), today announced positive top-line results from its SUS…
IVERIC bio Enters into Strategic Manufacturing Relationship with Catalent’s Paragon Gene Therapy for Orphan Inherited Retinal Diseases
NEW YORK & SOMERSET, N.J.–(BUSINESS WIRE)–IVERIC bio and Catalent entered into an agreement for production and manufacturing of AAV vector for IVERIC bio’s gene therapy product candidates.
Noveome Biotherapeutics, Inc. Announces the First Patient Dosed in Phase 2 Open Label Clinical Trial Evaluating Topical Ocular Delivery of ST266 For the Treatment of Persistent Corneal Epithelial Defects
PITTSBURGH–(BUSINESS WIRE)–Noveome Biotherapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing next-generation biologics for the promotion and restoration of cellular integrity of inflamed or damaged tissues, today announc…
Aerie Pharmaceuticals to Present at Two Upcoming Investor Conferences
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucom…
Jon Morgan Joins Eyecare Services Partners as Chief Information Officer
DALLAS–(BUSINESS WIRE)–Eyecare Services Partners (ESP), the national leader in integrated eye care services, announced the appointment of Jon Morgan as Chief Information Officer effective today. Mr. Morgan leads Information Technology for ESP, which …
Rick Hoffner Joins Eyecare Services Partners as Vice President of Operations, Central Region
DALLAS–(BUSINESS WIRE)–Eyecare Services Partners (ESP), the national leader in integrated eye care services, announced the appointment of Rick Hoffner as Vice President of Operations for the Central Region, effective today. Mr. Hoffner will lead the …
Aerpio Initiates Phase 1b Clinical Trial of Topical Ocular Formulation of AKB-9778 for Primary Open Angle Glaucoma
CINCINNATI–(BUSINESS WIRE)–Aerpio Pharmaceuticals, Inc. (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases and diabetic complications, today announced dosing of the first subject in…
NovaBay Pharmaceuticals Launches Avenova® Direct on Amazon.com
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing Avenova® for the domestic eye care market, announces that Avenova® Direct is available at affordable prici…
Acucela Receives Orphan Designation From the EMA for Emixustat for the Treatment of Stargardt Disease
SEATTLE–(BUSINESS WIRE)–Acucela Inc. (“Acucela”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), announced today that the European Medicines Agency (EMA) granted orphan des…
Global $673.2Mn Optical Lens Edgers Market Outlook Report, 2026 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Optical Lens Edgers Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018-2026” report has been added to ResearchAndMarkets.com’s offering. The global optical lens edgers market was valued at US$ 380.5 million in 2017 and is expected to reach US$ 673.2 million by 2026, expanding at a CAGR of 6.7% from 2018 to 2026. Key Market Movements Growing senescent population and increas
Global Vision Care Market 2019-2023 – Shift to E-commerce Platforms & Growing Preference for Daily Disposable Contact Lenses – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Vision Care Market: Size, Trends and Forecast (2019-2023)” report has been added to ResearchAndMarkets.com’s offering. Global Vision Care Market: Size, Trends and Forecast (2019-2023) provides an in-depth analysis of the vision care market including a detailed description of market sizing and growth. The report provides an analysis of the global vision care market by value and by segments. The report also includes a detailed segment analysis of the vision ca
Researchers Study Improvement in Patient Compliance and Screening Efficacy by Using the EyeArt AI Eye Screening System for Detecting Diabetic Retinopathy
LOS ANGELES–(BUSINESS WIRE)–Improvement in Patient Compliance and Screening Efficacy by Using the EyeArt AI Eye Screening System for Detecting Diabetic Retinopathy